EZH2 and non-small cell lung carcinoma: For instance, EZH2-mediated H3K27me3 trimethylation suppresses the expression of tuberous sclerosis complex 2 (TSC2), thereby inhibiting autophagy and reducing NSCLC cell resistance to cisplatin (97).